Modalis Therapeutics Corporation (TYO:4883)
Japan flag Japan · Delayed Price · Currency is JPY
45.00
+2.00 (4.65%)
May 29, 2026, 3:30 PM JST

Modalis Therapeutics Balance Sheet

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,8122,8123,5751,8832,9334,936
Cash & Short-Term Investments
2,8122,8123,5751,8832,9334,936
Cash Growth
-21.01%-21.34%89.86%-35.80%-40.58%-8.95%
Inventory
---640-
Other Current Assets
7880426788131
Total Current Assets
2,8902,8923,6171,9563,0615,067
Property, Plant & Equipment
-----223
Long-Term Investments
517174696873
Other Intangible Assets
-----705
Other Long-Term Assets
11---1
Total Assets
2,9422,9643,6912,0253,1296,069
Accounts Payable
-11--1
Accrued Expenses
292520911725
Current Income Taxes Payable
8410795105123126
Other Current Liabilities
2112128
Total Current Liabilities
115134117198141180
Long-Term Debt
---412--
Long-Term Deferred Tax Liabilities
-----5
Other Long-Term Liabilities
2938283649335
Total Liabilities
144172145646190520
Common Stock
1,8891,7281,7581,2172,0942,744
Additional Paid-In Capital
3,2113,0493,0802,5393,4164,066
Retained Earnings
-2,363-2,037-1,325-2,410-2,605-1,266
Comprehensive Income & Other
61523333345
Shareholders' Equity
2,7982,7923,5461,3792,9395,549
Total Liabilities & Equity
2,9422,9643,6912,0253,1296,069
Total Debt
---412--
Net Cash (Debt)
2,8122,8123,5751,4712,9334,936
Net Cash Growth
-21.01%-21.34%143.03%-49.85%-40.58%-8.95%
Net Cash Per Share
34.5436.3977.5047.50100.77171.67
Filing Date Shares Outstanding
88.989.5573.5533.8130.0929.04
Total Common Shares Outstanding
88.986.6769.433.3629.3628.97
Working Capital
2,7752,7583,5001,7582,9204,887
Book Value Per Share
31.4732.2151.0941.34100.09191.56
Tangible Book Value
2,7982,7923,5461,3792,9394,844
Tangible Book Value Per Share
31.4732.2151.0941.34100.09167.22
Source: S&P Global Market Intelligence. Standard template. Financial Sources.